Literature DB >> 28420819

Synonymous and Biased Codon Usage by MERS CoV Papain-Like and 3CL-Proteases.

Mahmoud Kandeel1,2, Abdallah Altaher1.   

Abstract

Middle East respiratory syndrome coronavirus (MERS CoV) is a recently evolved fatal respiratory disease that poses a concern for a global epidemic. MERS CoV encodes 2 proteases, 3C-like protease (3CLpro) and papain-like protease (PLpro). These proteases share in processing MERS CoV polyproteins at different sites to yield 16 nonstructural proteins. In this work, we provide evidence that MERS CoV 3CLpro and PLpro are subject to different genetic and evolutionary influences that shape the protein sequence, codon usage pattern, and codon usage bias. Compositional bias is present in both proteins due to a preference for AT nucleotides. Thymidine (T) was highly preferred at the third position of codons, preferred and overrepresented codons in PLpro, but was replaced by guanosine (G) in 3CLpro. Compositional constraints were important in PLpro but not in 3CLpro. Directed mutation pressure seems to have a strong influence on 3CLpro codon usage, which is more than 30-fold higher than that in PLpro. Translational selection was evident with PLpro but not with 3CLpro. Both proteins are less immunogenic by showing low CpG frequencies. Correspondence analysis reveals the presence of 3 genetic clusters based on codon usage in PLpro and 3CLpro. Every protein had one common cluster and 2 different clusters. As revealed by correspondence analysis, the number of influences on codon usage are restricted in MERS CoV 3CLpro. In contrast, PLpro is controlled by a broader range of compositional, mutational, and other influences. This may be due to the multifunctional protease, deubiquitination, and innate immunity suppressing profiles of PLpro.

Entities:  

Keywords:  codon usage; coronavirus; evolution; protease; synonymous codon

Mesh:

Substances:

Year:  2017        PMID: 28420819     DOI: 10.1248/bpb.b17-00168

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  8 in total

1.  Analysis of Codon Usage and Nucleotide Bias in Middle East Respiratory Syndrome Coronavirus Genes.

Authors:  Snawar Hussain; Pottathil Shinu; Mohammed Monirul Islam; Muhammad Shahzad Chohan; Sahibzada Tasleem Rasool
Journal:  Evol Bioinform Online       Date:  2020-05-04       Impact factor: 1.625

2.  Deciphering the co-adaptation of codon usage between respiratory coronaviruses and their human host uncovers candidate therapeutics for COVID-19.

Authors:  Komi Nambou; Manawa Anakpa
Journal:  Infect Genet Evol       Date:  2020-07-22       Impact factor: 3.342

3.  Repurposing of FDA-approved antivirals, antibiotics, anthelmintics, antioxidants, and cell protectives against SARS-CoV-2 papain-like protease.

Authors:  Mahmoud Kandeel; Alaa H M Abdelrahman; Kentaro Oh-Hashi; Abdelazim Ibrahim; Katharigatta N Venugopala; Mohamed A Morsy; Mahmoud A A Ibrahim
Journal:  J Biomol Struct Dyn       Date:  2020-06-29

4.  Analysis of preferred codon usage in the coronavirus N genes and their implications for genome evolution and vaccine design.

Authors:  Abdullah Sheikh; Abdulla Al-Taher; Mohammed Al-Nazawi; Abdullah I Al-Mubarak; Mahmoud Kandeel
Journal:  J Virol Methods       Date:  2020-01-05       Impact factor: 2.014

5.  Molecular dynamics of Middle East Respiratory Syndrome Coronavirus (MERS CoV) fusion heptad repeat trimers.

Authors:  Mahmoud Kandeel; Abdulla Al-Taher; Huifang Li; Udo Schwingenschlogl; Mohamed Al-Nazawi
Journal:  Comput Biol Chem       Date:  2018-05-17       Impact factor: 2.877

Review 6.  Update of the current knowledge on genetics, evolution, immunopathogenesis, and transmission for coronavirus disease 19 (COVID-19).

Authors:  Kalthoum Tizaoui; Ines Zidi; Keum Hwa Lee; Ramy Abou Ghayda; Sung Hwi Hong; Han Li; Lee Smith; Ai Koyanagi; Louis Jacob; Andreas Kronbichler; Jae Il Shin
Journal:  Int J Biol Sci       Date:  2020-09-12       Impact factor: 6.580

Review 7.  Molecular Characteristics, Functions, and Related Pathogenicity of MERS-CoV Proteins.

Authors:  Yan-Hua Li; Chen-Yu Hu; Nan-Ping Wu; Hang-Ping Yao; Lan-Juan Li
Journal:  Engineering (Beijing)       Date:  2019-07-17       Impact factor: 7.553

8.  From SARS and MERS CoVs to SARS-CoV-2: Moving toward more biased codon usage in viral structural and nonstructural genes.

Authors:  Mahmoud Kandeel; Abdelazim Ibrahim; Mahmoud Fayez; Mohammed Al-Nazawi
Journal:  J Med Virol       Date:  2020-03-16       Impact factor: 2.327

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.